Risky treatment halts MS

Alex Normandin was in 3rd year medical school when he underwent a risky treatment for aggressive multiple sclerosis as part of an experimental trial led by the Neuro.

http://www.montrealgazette.com/health/Risky+treatment+gives+doctor+life+back/8179030/story.html